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 Tissue engineering, the primary therapeutic approach to achieving regeneration following 
traumatic injury or disease, is a complex undertaking. As the therapeutic window of most neurotrophic 
factors remains largely unknown, a simple, flexible platform is necessary in order to bioassay neurotrophic 
factors and determine how their complex interplay influences cellular response and regenerative processes. 
Factors such as scaffold material, topographic cues, incorporation of cells, and delivery of biochemical 
signals must all be considered in order to design a successful engineered graft that allows for these aspects 
to be studied in a single, inclusive system. Thus, we have developed an easily scalable method of surface 
modifying electrospun hydrogel microfibers to further enhance the utility of aligned hydrogels used in 
tissue regeneration. Using EDC/NHS coupling, we are able to conjugate heparin to the surface of any 
biopolymer hydrogel that contains primary amines in order to achieve sustained release of biochemical 
cues at the target site. Topographic cues are presented via the scaffold itself; the hydrogel environment 
mimics the native extracellular matrix and provides a 3D culture environment for cells. Additionally, 
electrospinning induces alignment of fibers, which increases the strength of our scaffolds while directing 
cell growth in the orientation of the fibers. Finally, surface modification of electrospun fibers with heparin 
allows for the capture and controlled delivery of growth factors without affecting the properties of the 
biopolymer and, by consequence, altering hydrogel formation. Neural stem cells seeded as spheroids onto 
unmodified electrospun fibrin hydrogel scaffolds were observed migrating out and spreading in the 
direction of fibers. We found that heparin itself inhibited cell outgrowth and spreading, but capture of glial-
derived neurotrophic factor by heparin when GDNF was presented in concentrations as low as 2 ng/ml 
appeared to counteract inhibition by heparin alone and promote cell spreading. Astrocytes and neurons 
were both detected at D21 on heparinized fibers, regardless of extent of spreading on fibers, whereas by 
D21, nonheparinized fibers stained positive almost exclusively for neurons. As astrocytes have the ability 
to enhance neuronal survival and regeneration, the presence of both neurons and astrocytes in culture can 
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Bioengineered grafts with properties that can be tuned to address specific, clinical needs have been 
widely studied and sought after as an alternative to autografts, the clinical gold standard in many tissue 
engineering applications such as cardiac, vascular, orthopedic, spinal cord, and musculoskeletal 
regeneration.[1] Autotransplantation involves the harvesting of bone or tissue from donor sites within the 
patient. While there is no risk of disease transfer or rejection of autografts, there are a multitude of 
challenges associated with transplantation of autografts, including the need for a secondary injury, donor 
site morbidity, limited availability of sufficiently sized autograft material for optimal repair, and variability 
of autograft efficiency.[2] In the context of nerve regeneration, nerve guidance conduits (NGCs) are the 
primary engineering solution to circumventing additional surgery and comorbidities, thus potentially 
matching or outperforming nerve autografts. NGCs guide axonal sprouting from the proximal to distal 
stump, prevent neuroma formation and excessive branching, and protect the injury site. Successful NGCs 
should be capable of concentrating neurotrophic factors, reducing cellular invasion and scarring of the 
nerve, and mimicking the native extracellular matrix (ECM), which consists of an intricate network of 
glycosaminoglycans, structural proteins, and matricellular proteins.[3] This network works together to carry 
out complex signaling events and provide structural support for many cellular processes. A myriad of 
factors must be considered in the design of NGCs in order to provide a favorable, ECM-like 
microenvironment to improve nerve regeneration. To facilitate the exchange of nutrients between the 
lumen and outer environment, engineered grafts must be semi-permeable. They must also be constructed of 
reabsorbable biomaterials for successful long-term recovery. Materials selection becomes a critical factor 
when tailoring degradation rates of NGCs for specific applications, as it is assumed that the release of a 
protein or drug from NGCs follows polymer degradation kinetics.[4] NGC materials are generally 
categorized as nonresorbable or resorbable, the latter being of greater interest in creating the ideal nerve 
conduit. Biodegradable materials commonly used in NGCs include collagen, gelatin, fibrin, alginate, 
polyglycolic acid, and chitosan.[5] Another design aspect to consider is incorporation of cells and growth 
factors into artificial nerve grafts. Cells secrete their own neurotrophic factors and express cell-adhesion 
molecules to enhance regeneration by promoting neurite outgrowth and neuronal survival. Neurotrophic 
factors such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) increase dendritic 
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and axonal branching as well as the number and localization of synaptic vesicles at the site of 
neurotransmitter release. Meanwhile, cell adhesion molecules influence synapse formation by inducing 
synapse specification, adhesion, and signaling. They also induce pre-synaptic and post-synaptic 
differentiation.[6] These endogenous biomolecules can be further supplemented by the exogenous growth 
factors delivered to the target site.[2] Since the effects of growth factors are dose-dependent, their 
therapeutic windows and labyrinthine biological effects must be studied carefully to select the most suitable 
factors in appropriate quantities to optimize regeneration. 
To match or surpass the performance of autografts, scaffolding in tissue engineering must mimic the 
structure and functions of the native ECM. In native tissue, ECM provides structural support for cells, 
supplies growth factors and potentiates their activity, provides bioactive cues to cells to respond to their 
microenvironment, and imparts mechanical strength to tissues.[7] The vast variety of scaffold choices for 
tissue engineering is best narrowed down by considering the desired application for the scaffold. 
Hydrogels, for instance, are a principal scaffold material used for constructing artificial nerve grafts. These 
swollen networks are lightly cross-linked polymer chains that can be reversibly dehydrated and reswollen 
depending on environmental conditions, thereby enabling drug uptake and release.[5] Hydrogel scaffolds 
must provide specific structural, mechanical, and biochemical cues to cells in a controlled manner in order 
to guide cells spatially and temporally towards tissue formation and nerve regeneration.[5] Mechanical and 
physical features that influence the efficacy of a hydrogel for tissue regeneration include the overall 
architecture, physical dimensions, strength, stiffness, mesh size, and porosity of the gel as well as the 
biomaterials used in constructing the gel. Biocompatibility with tissues and release of therapeutic agents 
also play critical roles in hydrogel performance. These features must all be carefully evaluated when 
designing and constructing ECM-like hydrogel scaffolds that provide mechanical support for dendritic 
growth as well as biological signals to direct axonal growth towards the distal stump in nerve 
regeneration.[5]  
Due to its relative simplicity and versatility, electrospinning is a popular technique used to generate 
random or aligned nanofibers for tissue engineering applications. Fiber diameter influences cell 
proliferation and migration; migration is limited essentially to the surface of scaffolds for fiber diameters 
below 0.25 m, while optimal depth migration and proliferation is believed to occur on fibers with 
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diameters above 2 m.[8] Using electrospinning, we are able to easily tune fiber diameter as well as 
reproducibly create fibers with diameters on the micron scale. High biocompatibility, biodegradability, 
reproducibility, scalability, and cost effectiveness are additional factors that are considered in designing 
electrospun fibrous scaffolds that not only bear strong morphological resemblance to the native ECM but 
also function as delivery systems. Fibers can be made from a wide range of starting natural materials, 
including fibrin, alginate, gelatin, and hyaluronic acid, which are selected to match the properties and 
projected time of regeneration of the injured tissue or nerve.[9, 10] The elastic modulus of central nervous 
system tissue is typically reported in the range of 3-300 kPa for spinal cord tissue and approximately 500 
Pa for brain tissue, making highly swollen yet easy to handle electrospun hydrogels an ideal choice for 
scaffolding material.[11] The loose bonding between electrospun fibers is also believed to stimulate tissue 
growth and cell migration, while encapsulation of growth factors within electrospun scaffolds can 
potentially further improve regeneration.[4] The basis of electrospinning entails applying a high voltage to a 
polymer solution that is extruded at a fixed rate.  As the droplet at the needle tip becomes highly electrified, 
the applied electric field overcomes the solution viscosity and tends to form a Taylor cone. When the 
electric field threshold is surpassed, a finely charged polymer jet emerges from the tip of the Taylor cone 
and sprays as a continuous fiber onto a grounded collector.[12]  
We utilize a variation of the classic electrospinning technique to generate hydrogel microfibers 
(Appendix 1).[10] Aqueous polymer solutions are extruded into a rotating collection bath where they are 
rapidly cross-linked to form hydrogel microfibers. Spinning onto a wet cross-linking bath rather than a dry 
collecting sheet allows us to easily alter cross-linking density. Alignment of fibers is a combined result of 
electrical and mechanical stretching. The electric field applied to the polymer solution induces dipole 
alignment of polymer chains, while the rotation of the collection wheel mechanically stretches the polymer 
jet as it lands in the cross-linking solution. Fiber diameter can be manipulated by adjusting separation 
distance between polymer jet and collection wheel as well as weight percent of material spun. Additional 
factors that influence fiber diameter include rotation speed of the collection bath and solution extrusion 
rate, such that at lower rotation speeds and lower extrusion rates, microfibers rather than nanofibers are 
formed. Uniaxial alignment of hydrogel fibers synthesized using this method has previously been 
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confirmed using scanning electron microscopy and small angle X-ray scattering and shown to improve the 
mechanical properties of the hydrogel fibers.[10] 
In this study, fibrin hydrogels were formed using this modified electrospinning method.  Fibrinogen is 
a rod-shaped protein with molecular weight of 340 kDa and can be obtained autologously, thus 
significantly reducing potential risks of foreign body reaction and viral infection.[13] Thrombin-mediated 
cross-linking converts fibrinogen into stable fibrin networks. Fibrin and fibrinogen play prominent roles in 
pathological processes such as wound healing, inflammatory response, cellular and matrix interactions, 
blood clotting, fibrinolysis, and neoplasia. Fibrin scaffolds are most widely used in the form of hydrogels, 
microbeads, and glues (commercially sold as Tissucol/Tisseel®, Evicel®, and Crosseal™).[15] Furthermore, 
due to its great biocompatibility and biodegradability, fibrin has been used as a hemostatic agent in clinical 
cardiac, spleen, and liver surgeries.[12] Cells entrapped in fibrin gel have been shown to produce more 
collagen and elastin, which confer structural support.[13]  The utility of fibrin scaffolds can be further 
improved by the incorporation of biologically active materials to facilitate cell adhesion. Despite the 
excellent versatility and biocompatibility of fibrin scaffolds, setbacks include loss of shape due to 
disintegration of gels before proper regeneration and low mechanical stiffness.[14] Using the altered 
electrospinning method described above, we were able to synthesize fibrin hydrogels of suitable 
mechanical strength, stiffness, and cross-linking density to combat these reported disadvantages without 
any loss of adaptability or compromised functionality.  
We aimed to incorporate biochemical cues into our hydrogel scaffolds in order to augment their utility 
and functionality. Commonly used methods of loading biomolecules into electrospun fibers include 
submerging scaffolds in an aqueous phase of proteins, blend electrospinning, and coaxial electrospinning. 
Dipping scaffolds into soluble protein soak baths allows proteins to attach directly via physical absorption 
with little interference to the bioactivity of the loaded biomolecules. However, uncontrolled release profiles 
present risks such as toxicity, burst release of drugs, and low reproducibility. Blend, or emulsion, 
electrospinning involves mixing proteins directly with polymer solutions prior to electrospinning. While 
this is seen as a relatively facile approach, protein distribution on the fibers tends to be heterogeneous and a 
decrease in the bioactivity of the loaded protein is frequently observed. Neither method is suitable for the 
highly aqueous fibers we generate using our electrospinning setup, as any proteins spun with the polymeric 
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scaffolding material quickly diffuse out into the collection bath of much greater volume. Furthermore, the 
stability of the fibers themselves can be compromised by the addition of proteins to the precursor solution. 
Coaxially electrospun fibers are generated by simultaneously and coaxially electrospinning the polymer 
and protein solutions through different inlet channels into one nozzle to for a core-shell structure. The 
resultant fibers have a homogeneous protein distribution throughout the fibers.[4] Due to electric charges 
being located primarily at the outer fiber surface, inner protein solutions are shielded from degradation by 
this shell barrier. Release profiles from coaxial electrospun fibers indicate initial burst release followed by a 
stage of sustained release, likely due to the longer diffusion path through the core-shell structure. Despite 
this, the physical entrapment of proteins in the core of coaxial electrospun fibers still does not address the 
short biological half-life of proteins. Additionally, proteins that are charge sensitive may be difficult to 
incorporate into the actual electrospinning process or affect assembly and mechanical strength of fibers.[16]  
Thus, we sought a method of  binding growth factors to the surfaces of our hydrogel fibers post-
electrospinning in order to enhance capture and retention of soluble factors present in soak solution. 
Covalent immobilization has been shown in the literature to retain growth factors for longer periods of 
time at the target site.[17] Free diffusion is hindered when growth factors are tethered to scaffolds, thereby 
offering control over the amount and distribution of biochemical cues in delivery systems. As immobilizing 
growth factors prolongs growth factor release, biological activity must be maintained for the duration of the 
projected regeneration time. Initial burst release can inhibit axonal sprouting by downregulating growth 
factor receptors and thus reducing affinity binding of these receptor sites to growth factors.[18] In order to 
develop efficient neurotrophic factor delivery systems, problems of protein instability, control over release 
kinetics, and unclear therapeutic windows must be elucidated. Loss of bioactivity may arise from blockage 
of specific functional groups on growth factors via chemical conjugation to scaffolds. Compromised 
biological activity not only detracts from the therapeutic potential of a delivery system but can also induce 
negative immunogenic effects. Furthermore, inadequate dosage and ill-defined release kinetics can lead to 
aberrant axonal growth. Finally, while it is widely accepted that neurotrophic factor effects are dose-
dependent, the complicated interplay of neurotrophic factors present in regenerative processes remains 
largely unknown. Therefore, selecting a facile yet efficient conjugation reaction that can easily be scaled up 
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to broadly assay the effects of soluble, heparin-binding neurotrophic factors on cellular response in a host 
of tissue engineering applications is a critical factor in the development of delivery systems. 
One class of affinity-based delivery system that is frequently employed exploits heparin as a carrier of 
biomolecules. With respect to fibrin scaffolds, heparin-immobilized neurotrophin-3 within fibrin gels has 
been shown to enhance neuronal outgrowth from chick dorsal root ganglia (DRGs) and increase neural 
fiber density in rat spinal cord lesions. Likewise, enhanced neurite extension from chick DRGs placed 
inside fibrin matrices containing -NGF bound to heparin has been reported. [19-21] Heparin is a linear 
polysaccharide that is comprised of alternating hexuronic acid and glucosamine residues.[22] It has broad 
uses in biomedical applications, including drug delivery, cell differentiation, reducing material 
thrombogenicity, and promoting material self-assembly. Heparin is capable of interacting strongly with 
different proteins in very specific manners as a result of its unique structure and surface charge distribution. 
It has been shown to sequester endogenous growth factors secreted in vitro or in vivo, and protects proteins 
that contain heparin-binding sites from degradation by stabilizing and immobilizing them within 
biomaterial matrices. Growth factors bind electrostatically to the carboxylic acid and acidic sulfate moieties 
on heparin through their heparin-binding domains.[10] The binding of proteins to heparin-based delivery 
systems in vitro mimics the interactions between growth factors and delivery systems that occur naturally 
within native ECM proteoglycans. Controlled growth factor release in heparin-affinity systems is 
moderated by enzymatic degradation of scaffolds, underscoring the importance of fiber degradation as a 
scaffold design factor. Accordingly, heparin was selected as a drug carrier for our study due to the stability, 
flexibility, and scalability it affords. Additionally, many central nervous system growth factors contain 
heparin-binding domains, including glial cell-derived neurotrophic factor (GDNF), bFGF, BDNF, 
neuregulin (NRG), and vascular endothelial growth factor (VEGF).[23, 24] Surface modification of fibrin 
scaffolds was carried out using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), which was used to 
activate the  carboxyl groups in heparin. Activated heparin was then reacted with the primary amines on the 
surface of the fibrin fibers. This method of surface modification using heparin takes place after 
electrospinning; therefore, the stability of the hydrogel fibers remains unperturbed. Furthermore, this 
heparinization approach can be employed to functionalize any biopolymer hydrogel that contains either 
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primary amines or carboxylic acid groups when a diamine linker is used, making it a suitable choice for a 
variety of tissue engineering applications.  
Neurotrophic factors (NTFs) are polypeptides that are known to regulate nerve cell survival and 
differentiation in both peripheral and central nervous system development. NTFs in circulation have 
inadequate release kinetics and short biological half-lives, typically on the order of minutes to a few hours 
at best depending on the particular growth factor. Drug delivery systems are thus designed to provide 
sustained release of sufficient concentrations of bioactive NTFs at target sites while protecting them from 
rapid degradation in vivo.[3] Biological processes are influenced by the concerted actions of many NTFs. 
Accordingly, in the delivery of multiple therapeutic agents, the different time courses of release required 
for each factor must be optimized. While it is known that NTFs generally influence cell behavior at very 
low concentrations in the range of 10-9 to 10-11 M, proper design must also consider that NTFs usually elicit 
biphasic responses. At low concentrations, NTF dosage is insufficient to activate cells. At high 
concentrations, the amount of NTF presented saturates receptors and can be toxic to cells.[13] It follows that 
the selection of optimal therapeutic agents in appropriate doses for specific applications is another key 
factor in improving the performance of delivery systems. 
Extensive bioassays are required to understand the therapeutic windows and complex interactions 
among neurotrophic factors that remain largely unknown. Hence, choice of cell line and relevant 
neurotrophic factors are critical design factors. Neural stem cells are self-renewing, multipotent cells that 
can proliferate and generate the main cell lineages of the nervous system: neurons, astrocytes, and 
oligodendrocytes. They are considered the optimal cell type for cell mediated therapy of neural disorders, 
as they are derived from the same tissue as damaged cells and display strong responsiveness to local 
environmental cues. Evidence suggesting that human neural stem cells (hNSCs) secrete GDNF, BDNF, 
VEGF, and insulin-like growth factor 1 (IGF-1), provides hope that they may protect dysfunctional motor 
neurons and increase dopaminergic neuron survival in animal models of neurodegenerative disease.[25] 
Thus, great effort has been invested in developing neural stem cell based strategies of treatment for 
neurodegenerative diseases and stroke. Transplantation of neural stem cells has been explored for treatment 
of Parkinson’s disease, Alzheimer’s disease, spinal cord injury, Huntington’s disease, and multiple 
sclerosis while the delivery of human neural stem cells at multiple sites along the spinal cord has been 
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investigated for treatment of amyotrophic lateral sclerosis. Neural stem cells have also been modified to 
produce necessary cytokines to treat brain tumors and cell replacement therapy using hNSCs has been 
studied for treating stroke patients.[25]  
For our study, we first studied the effects of GDNF on NSC proliferation. GDNF is a key factor for 
motor axonal regeneration due to its ability to promote axonal elongation and survival.[3] GDNF was 
captured by fibrin scaffold surfaces modified with heparin in order to study differences in cellular response 
when growth factors are delivered in bound or soluble form. The versatility of the drug delivery system we 
have developed is apparent in the flexibility of scaffolding material, cell type, and growth factor selection. 
Thus, the platform can be used to illuminate the delicate balance and roles of growth factors in the complex 
biological processes that govern tissue and nerve regeneration.  
 
 
2. Materials and Methods 
2.1 Materials and reagents 
Fibrinogen from bovine plasma, thrombin from human plasma, goat serum, poly(ethylene) oxide (PEO, 
average Mv ~ 4,000,000), lysozyme, accutase, laminin, and epidermal growth factor (EGF), N-
Hydroxysuccinimide 98% (NHS) were purchased from Sigma-Aldrich. 1-Ethyl-3-(3-
dimetylaminopropyl)carbodiimide (EDC) was purchased from Santa Cruz Biotechnology, Inc.  
 Glial-derived neurotrophic factor (GDNF) was purchased from PeproTech. Human plasmin was obtained 
from Athens Research & Technology, Inc. Human neural stem cells were obtained from EMD Millipore. 
Neurobasal medium, B-27 supplement, N-2 supplement, and basic fibroblast growth factor (bFGF) were 
purchased from Gibco. Aprotinin was purchased from Quality Biological, Inc. Anhydrous calcium chloride 
was purchased from Fisher Scientific. CellTracker™ Red CMTPX Dye and alamarBlue® Cell Viability 
Reagent were purchased from Life Technologies. Rabbit anti-III-Tubulin, rabbit anti-GFAP, mouse anti-
Nestin, and mouse anti-MAP2 antibodies were purchased from Invitrogen. Cy3 anti-rabbit and Alexa488 
anti-mouse were purchased from Jackson ImmunoResearch. Heparin sodium salt from porcine intestinal 
mucosa was purchased from Calbiochem. Lightning-Link FITC and Lightning-Link Rapid Fluorescein 
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Antibody Labeling Kits were purchased from Novus Biologicals. Micro-molds were obtained from 
MicroTissues, Inc.   
 
2.2 Electrospinning of hydrogel scaffolds 
0.5 wt% fibrinogen was dissolved in 0.2 wt% PEO at 37°C for 20 min, filtered using a 0.2 m filter, 
then placed in a 1 ml syringe fitted with a blunted 27 G needle tip. A 40 ml 50 mM CaCl2
 collection 
solution containing 20 U/ml thrombin was filtered and deposited on a grounded, aluminum collection 
wheel rotating between 30-40 rpm. The syringe pump holding the spinning solution was programmed to 
deposit the solution at 3.5 ml/hr. An electrode was attached to the needle tip, the separation distance 
between the needle tip and the collection wheel was adjusted to approximately 3-3.5 cm from the collection 
wheel, and an electrical potential of 3.5 kV was applied to the polymer solution. The electrostatically 
charged polymer jet that formed at the needle tip was ejected into and cross-linked within the rotating 
collection bath. Scaffolds of fibrin microfibers were formed using a linear stage that rastered the syringe 
pump back and forth (45-60s for each full pass). The resulting bundle of fibers was given 5 additional 
minutes after spinning to cross-link further on the wheel. The fibrin sheets were then cut into 7 sections that 
were each wrapped on square polyethylene terephthalate frames and stored in 12-well plates filled with 
sterile DI water at 4°C until use.  
 
2.3 Surface modification of hydrogel scaffolds 
Heparin sodium salt was dissolved in 0.05 M MES to yield a 0.2 wt% solution. EDC and NHS were 
then added in ratios to heparin of 1:1 and 2:3 by weight, respectively. The solution was mixed for 15 min 
on a stir plate at room temperature. PBS was then added to yield a solution of 0.1 wt%, which was mixed 
for an additional 5 min on the stir plate. The activated heparin solution was filtered using a 0.2 m filter. 
Sterile fibrin scaffolds were immediately soaked in the filtered heparin solution for 1 hr at room 
temperature. Sheets were then washed 3 times for 15 min each in DI water on a shaker at room 
temperature, then stored in DI water at 4°C until use. 
Heparinization was confirmed using 0.1 wt% toluidine blue. Surface modified sheets were soaked in 
toluidine blue for 20 minutes, then washed 4 times in DI water on a shaker. Positively charged toluidine 
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blue binds electrostatically to negatively charged heparin, forming a stable, metachromatic heparin-
toluidine blue complex.[26] Thus, fibers that remained dark purple after washes indicated presence of 
heparin. 
 
2.4 Optimization of factor loading levels in scaffolds 
Modified fibrin scaffolds and unmodified fibrin scaffolds were soaked in 500 ng/ml and 1 g/ ml 
FITC-labeled lysozyme (n=3) overnight at 4C on a shaker. Lysozyme, approximately 14.3 kDa, was 
selected for its similar molecular weight to GDNF, approximately 15.1 kDa. Following the overnight soak, 
sheets were rinsed in PBS for 15 min at 1 ml/ sample on a shaker at room temperature. The solution was 
collected and replaced with fresh PBS, and the samples were incubated at 37°C. At 3 hr, 6 hr, D1, D3, D5, 
and D7, release baths were collected and the PBS was replaced. A plate reader was used to read the 
fluorescence of the release baths (excitation: 485 nm, emission: 528 nm). 
  Human GDNF was labeled with fluorescein. Modified and control scaffold groups were both loaded 
at 1 g/ ml labeled GDNF (n=3, each). After the overnight growth factor soak, sheets were rinsed in PBS 
for 15 min at 1 ml/ sample on a shaker at room temperature. The rinse baths were collected and replaced 
with fresh PBS, and the samples were incubated at 37C. At 6 hr, D1, D3, D5, D7, D10, and D14, release 
baths were collected and the PBS was replaced. A plate reader was used to read the fluorescence of the 
release baths (excitation: 485 nm, emission: 540 nm). 
 
2.5 NSC culture 
Differentiation media was formed by adding B-27 and N-2 NSC supplements to neurobasal medium. 
Differentiation media supplemented with 20 g/ml bFGF and 20 g/ml EGF is referred to as 
maintenance media. 
T75 tissue culture flasks were coated overnight with 20 g/ml laminin in 0.9 wt% NaCl. P7 human 
neural stem cells were plated on laminin-coated T75 flasks, expanded in maintenance media,  and cultured 
in an incubator at 37°C. Media was exchanged every other day, and hNSCs were passaged when confluent. 
NSCs between passages 8 and 12 were used in experiments. 
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2.6 NSC spheroid formation 
Micro-molds were sterilized in 70% ethanol prior to use. 1 wt% agarose was added to 0.9 wt% NaCl, 
microwaved in increments of 10-15 sec, and swirled until the agarose had fully dissolved. 330 l of the 
agarose solution was pipetted into each micro-mold and allowed to set for 20 min at room temperature. 
Agarose molds were carefully removed using round tip tweezers and stored in a 24-well plate filled with 
PBS. PBS was aspirated immediately before use. 
hNSCs cultured on T75 flasks were rinsed with PBS twice, then detached using accutase. Cells were 
spun down at 800 rpm for 4 min. The accutase and media were aspirated, leaving the cell pellet, which was 
then re-suspended in 500 l of NSC maintenance media. 90 l of trypan blue was added to 10 l of the 
resuspended cells, and an estimate of the number of the total number of NSCs was calculated based off of 
the number of stained cells counted in the hemocytometer. The resuspended cells were further diluted down 
to 50 cells/l in maintenance media, and 50 l of this dilution was pipetted into each agarose mold to 
yield approximately 71 cells per spheroid. Spheroids were placed on a shaker in an incubator for 45 min 
before 500 l of maintenance media was added to the sides of each well, carefully avoiding pipetting into 
the molds. The plates were returned to the shaker at 37C, and spheroids were given overnight to form.  
 
2.7 Spheroids culture on tissue culture polystyrene (TCPS) 
All plates used for 2D culture of spheroids on TCPS were coated overnight with 20 g/ml laminin in 
0.9 wt% NaCl. Prior to use, the laminin solution was aspirated off and maintenance media was added to 
each well. Spheroids were then added to each well and cultured at 37C for 7-21 days. Media was 
exchanged every other day, with fresh GDNF added to experimental groups at specific concentrations.  
 
2.8 Preparation of scaffolds for spheroid seeding 
Samples were divided into two groups: heparinized scaffolds and nonheparinized scaffolds. Within 
each group, three loading conditions were used: no GDNF (n=3), bound GDNF (n=3), and soluble GDNF 
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(n=3). 24 hours prior to spheroid seeding, all samples in the “bound GDNF” groups (heparinized and 
nonheparinized) were soaked overnight in a GDNF bath to load each sheet with 10 ng/ml GDNF (Table 1).  
Prior to seeding, all scaffolds were coated with 20 g/ml laminin in 0.9 wt% NaCl for 2 hours, then 
removed from the laminin baths and placed individually into 12-well plates to “dry out” for approximately 






























Initial GDNF on 
Fibers 
GDNF in Media Fiber Group 
Nonheparinized 0 ng/ml 0 ng/ml “No GDNF” 
0.1% heparin 0 ng/ml 0 ng/ml “No GDNF” 
    
Nonheparinized 0 ng/ml 2 or 10 ng/ml “Soluble GDNF” 
0.1% heparin 0 ng/ml 2 or 10 ng/ml “Soluble GDNF” 
    
Nonheparinized* 2 or 10 ng/ml 0 ng/ml “Bound GDNF” 
0.1% heparin* 2 or 10 ng/ml 0 ng/ml “Bound GDNF” 
 
Table 1. Loading and culture conditions were categorized into three groups: no GDNF, soluble GDNF, and 




















2.9 Spheroid seeding on scaffolds 
Using round tip tweezers, the agarose molds containing spheroids were flipped such that the bottoms 
of the molds were facing up. The plates were centrifuged at 400 rpm for 5 min to displace NSC spheroids 
from the molds. Agarose molds were checked under optical microscopy to ensure they had been emptied, 
and centrifugation was repeated as necessary. The empty agarose molds were then removed from the plates, 
and the spheroid suspension was collected from each well. The aggregate spheroid suspension was spun 
down at 400 rpm for 5 min, and the media was aspirated. The spheroids were resuspended in maintenance 
media at 20 l per mold. Spheroids were seeded onto scaffolds at 10 l of spheroid suspension per 
scaffold, then allowed to attach for 20 minutes before 200 l of maintenance media with 10 g/ml 
aprotinin was added carefully to the wells. After an additional hour, the remaining 800 l of maintenance 
media with aprotinin was added to each well to bring the final volume to 1 ml. Aprotinin was added to all 
media used for culturing NSCs on scaffold in order to prevent fibrinolysis. Samples were cultured at 37C 
over the course of 7-21 days depending on the study, and media was exchanged with the respective media 
conditions every other day. For the soluble GDNF condition, 10 ng/ml soluble GDNF was added to 
maintenance media with aprotinin at each media exchange.  For the no GDNF and bound GDNF 
conditions, plain maintenance media with aprotinin was added at each exchange. 
 
2.10 Immunostaining of spheroid-seeded scaffolds 
NSC-seeded scaffolds were rinsed with warm PBS then fixed with 4% PFA for 10 min. Fixed cells 
were rinsed 3 times in warm PBS, then permeabilized with 0.2% TritonX100 at room temperature. Samples 
were then washed 5 times with PBS and 0.5% BSA for 5 min each rinse, blocked for 2 hrs with 4% goat 
serum and 1% BSA in PBS, then washed again 5 times with PBS and 0.5% BSA for 5 min each rinse. For 
the first set of primary antibody staining, scaffolds were incubated with either rabbit anti-III-Tubulin 
1:1000 or rabbit anti-GFAP 1:2000 overnight at 4C. Samples were then washed 5 times with PBS and 
0.5% BSA for 5 min each rinse. Shielded from light, scaffolds were incubated with Cy3 anti-rabbit 1:200 
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for 2 hrs, rinsed 5 times with PBS and 0.5% BSA for 5 min each rinse, then blocked for 2 hrs with 4% goat 
serum and 1% BSA in PBS. For the second set of primary antibody staining, samples that had been 
incubated with anti-III-Tubulin previously were incubated with mouse anti-Nestin 1:500 overnight at 4
C. Samples that had been incubated with anti-GFAP first were incubated with mouse anti-MAP2 1:500 
overnight at 4C. Following overnight incubation, all scaffolds were washed 5 times with PBS and 0.5% 
BSA for 5 min each rinse, Scaffolds were incubated with Alexa488 anti-mouse 1:200 for 2 hrs, then 
washed 5 times with PBS and 0.5% BSA for 5 min each rinse. Finally, samples were imaged using a Zeiss 
Axio Observer.A1 microscope.  
 
2.11 NSC spheroid spreading 
NSCs in monolayer culture on a T75 tissue culture flask were labeled with CellTracker Red prior to 
spheroid formation as detailed above. Scaffold preparation and spheroid seeding were performed as 
detailed above, with the addition of a parallel set of all experimental groups cultured in differentiation 
media with 10 g/ml aprotinin rather than maintenance media (n=3 per culture group). Scaffolds were 
cultured at 37°C for 7 days. Media was exchanged every other day. Scaffolds were imaged daily using 
fluorescence microscopy. Images were analyzed in ImageJ to quantify outgrowth from spheroids. 
Spheroids from images taken at 4 hrs, D1, and D2 were outlined and measured using the freeform selection 
tool. All measurements for a specific time point and culture condition were added together to calculate 
overall area covered by cells on scaffolds. Changes in overall cell coverage area were calculated relative to 
spheroid size at 4 hr. At D7, scaffolds were rinsed with warm PBS, then fixed with 4% PFA for 10 min. 
Fixed cells were stained with Alexa Fluor 488 phalloidin and imaged under fluorescence microscopy using 
a Zeiss Axio Observer.A1 microscope. 
 
2.12 NSC spheroid proliferation 
To observe the effects of GDNF on NSC spheroid proliferation, spheroids were seeded on TCPS as 
described in Section 2.7.  At 1.5 hr post-seeding, media was replaced with 10% alamarBlue in maintenance 
media. After 2.5 hr of incubation, media was collected and absorbance was read using a plate reader 
(excitation: 540 nm, emission: 590 nm). Maintenance media or GDNF in maintenance media were added. 
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Spheroids were cultured in the following GDNF concentrations prepared in maintenance media: 0 ng/ml 
(control), 2 ng/ml, 5 ng/ml, 10 ng/ml, 25 ng/ml, 50 ng/ml GDNF. At D1, D3, D5, and D7, media was 
replaced with 10% alamarBlue for an incubation time of 2.5 hr before absorbance was read. All remaining 
media was aspirated, and different conditions of fresh GDNF in media were added to complete the media 
exchange. Spheroids were rinsed with warm PBS and fixed with 4% PFA at D7. 
 
 
3.  Results 
3.1 Heparinization of scaffold surfaces 
EDC was first used to activate the carboxyl groups in heparin and then to react the activated heparin 
with primary amines on surface of the fibrin fibers. NHS was added to the EDC-heparin solution to 
stabilize the amine-reactive intermediate, thus increasing the efficiency of the EDC coupling reaction. 
Fibrin hydrogel microfibers were soaked in this activated heparin solution for 1 hr to allow for surface 
modification. 
Toluidine blue was used to confirm successful functionalization of fibrin scaffolds. Following 20 min 
of incubation in toluidine blue, excess dye was washed off in a series of soaks in DI. All of the toluidine 
blue dye that was initially uptaken by unmodified fibers was cleared in the rinses with DI, such that the 
nonheparinized fibers appeared as they had prior to staining. On the other hand, samples functionalized 
with 0.1% heparin remained a deep purple color throughout the DI washes. To further confirm 
heparinization, both groups of fibers were treated with 0.5 CU/ml plasmin at 37°C. Unmodified fibers 
degraded within 4 hours, while heparinized fibers remained in tact overnight. Heparinized fibers were 
treated with an additional 0.5 CU/ml plasmin to combat any potential loss of bioactivity of plasmin at 37°C, 
but no evidence of fiber degradation was observed.  
We hypothesized that heparin bound to fibrin shields modified scaffolds from degradation by plasmin.  
To test this, another group of 0.1% heparinized fibrin scaffolds was incubated with 1 U/ml heparinase 
overnight at 37°C. After overnight heparinase treatment, modified scaffolds were soaked in 0.5 CU/ml 
plasmin overnight. Full degradation of fibers following sequential overnight treatments of heparinase and 
plasmin confirmed our hypothesis. The protection of fibrin by heparin offers great promise for enhancing 
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stability of fibrin scaffolds when subjected to biologically relevant conditions in vitro and eventually in 
vivo.  
 
3.2 Sustained release of biomolecules bound to surface-modified scaffolds 
Heparinized and nonheparinized fibers were loaded with FITC-labeled lysozyme in soak baths of 
either 500 ng/ml, 1 g/ml or 2 g/ml of lysozyme. Lysozyme (14 kDa) was chosen for the initial proof of 
concept study due to its similar size to growth factors such as GDNF (15 kDa), BDNF (14 kDa), and NGF 
(13 kDa). The release of lysozyme into PBS at 37°C was recorded over 7 days. Fibers with heparin showed 
lower release of FITC-lysozyme compared with the release from the nonheparinized control fibers at each 
time point, indicating capture and prolonged release of FITC-lysozyme from heparinized fibers (Fig. 1A-
C). D7 cumulative release from nonheparinized fibers loaded with 500 ng/ml lysozyme was 126.29 ng 
(86% uptake) compared to 85.36 ng (68.29% uptake) from heparinized fibers loaded with the same initial 
concentration of lysozyme. At a loading level of 1 g/ml lysozyme, cumulative releases of 150 ng (60% 
uptake) and 103.14 ng (41.26% uptake) were observed in nonheparinized and heparinized fibrin fibers 
respectively. Cumulative release from nonheparinized fibers loaded with 2 g/ml was measured as 356.82 
ng (51.36% uptake) and 150. 18 ng (30.04% uptake) from heparinized fibers loaded with 2 g/ml (Table 
2). Percent uptake did not increase with higher loading concentration; however, difference in cumulative 
release from nonheparinized and heparinized fibers increased by approximately 10% as loading level 
doubled. Standard deviations also increased monotonically in unmodified fibers. In heparinized fibers, 
standard deviations from 6 hr until D7 in samples loaded with 2 g/ml lysozyme were more than double 
those in fibers loaded with 500 ng/ml at the same sampling times (Fig. 1A, C). In heparinized fibers loaded 
with 1 g/ml lysozyme, standard deviations from release by D1 onward were lower than those for release 
from fibers loaded with 500 ng/ml lysozyme at corresponding time points. (Fig. 1B, C). In the literature, 
growth factors such as GDNF, VEGF, HGF, and BMP-2 have been found to have higher binding affinity to 
heparin compared to lysozyme, suggesting that release of these surface-captured factors would be even 
slower than that of the FITC-lysozyme.[27-30]   
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The study was repeated with heparinized and nonheparinized fibers loaded overnight with 
fluorescein-labeled GDNF. Cumulative release at D7 from fibers loaded with 500 ng/ml was approximately 
132.14 ng (105.81% uptake) in nonheparinized fibers and about 67.24 ng (53.79% uptake) from 
heparinized fibers (Fig. 2A). Higher cumulative release was observed from heparinized fibers (120.17 ng, 
48.07% uptake) compared to nonheparinized fibers (109.06 ng, 43.62% uptake) loaded with 1 g/ml 
GDNF (Fig 2B). Finally, a difference of 21.44% in uptake was measured between nonheparinized fibers 
and heparinized fibers (180.64 ng, 36.23% uptake vs. 73.45 ng, 14.69% uptake) loaded with 2 g/ml 
GDNF (Fig. 2C). The percent uptake that surpasses the theoretical loading in the nonheparinized fibers 
loaded with 500 ng/ml may be attributed to artificial increase in concentration due to evaporation of GDNF 
release solution collected, particularly at release volumes of 1 ml and at longer time points. Further 
investigation into fibrin’s affinity for GDNF could also potentially explain the observed release. Full 
degradation of fibers is needed to accurately assess the total amount of growth factor loaded into both 
heparinized and nonheparinized fibers. We have observed that heparin bound to fibrin protects fibrin from 
degradation in PBS at 37°C, while unmodified fibers begin fragmenting and appear looser on the frames by 
D14. Previously, 0.25 CU/ml plasmin was used to degrade nonheparinized fibrin fibers overnight at 37°C 
(data not shown). However, heparinized fibers remained intact after multiple treatments with plasmin at 
37°C. We hypothesize that the high negative charge that heparin imparts to modified fibers protects them 
degradation via plasmin. Future studies using heparinase to dissociate heparin from fibrin, followed by 
treatment of the exposed fibrin with plasmin, could provide a means for determining total uptake. Finally, 
high standard deviations as well as indistinct trends with varying loading concentration may be attributed to 
degradation of fluorescein. An enzyme linked immunosorbent assay (ELISA) can alternatively be used to 
measure release and would be particularly useful at later time points since the detection limit of the assay is 









Table 2. Percent uptake and D7 cumulative release of either FITC-labeled lysozyme or fluorescein-labeled 
GDNF on nonheparinized and heparinized fibers at varying loading levels. Percent uptake and cumulative 
release were higher in nonheparinized fibers than in heparinized fibers at all tested loading concentrations 
of lysozyme. Likewise, percent uptake and cumulative release were both higher in nonheparinized fibers 
than in heparinized fibers loaded with 500 ng/ml and 2 g/ml GDNF. However, greater uptake and release 









Type of Microfiber 
Scaffold 
Initial Concentration 




Release of Protein 
Nonheparinized 500 ng/ml lysozyme 86% 126.29 ng 
0.1% Heparin 500 ng/ml lysozyme 68.29% 85.36 ng 
    
Nonheparinized 1 μg/ml lysozyme 60% 150 ng 
0.1% Heparin 1 μg/ml lysozyme 41.26% 103.14 ng 
    
Nonheparinized 2 μg/ml lysozyme 51.36% 356.82 ng 
0.1% Heparin 2 μg/ml lysozme 30.04% 150.18 ng 
    
Nonheparinized 500 ng/ml GDNF 105.81% 132.14 ng 
0.1% Heparin 500 ng/ml GDNF 53.79% 67.24 ng 
    
Nonheparinized 1 μg/ml GDNF 43.62% 109.06 ng 
0.1% Heparin 1 μg/ml GDNF 48.07% 120.17 ng 
    
Nonheparinized 2 μg/ml GDNF 36.23% 180.64 ng 

























Release profile of fibrin scaffolds loaded with 2 g/ml FITC-labeled lysozyme (n=3). 
 
Fig. 1. Cumulative release of FITC-labeled lysozyme from 0.5 wt% fibrin fibers, nonheparinized (        ) vs. 
modified with 0.1% heparin (       ), over 7 days in PBS at 37°C. Fibers were loaded in overnight baths of 
(A) 500 ng/ml, (B) 1 g/ ml, (C) or 2 g/ ml FITC-labeled lyszoyme. Heparinized fibers showed lower 


















































































Release profile of fibrin scaffolds loaded with 2 g/ml fluorescein-labeled GDNF (n=3).  
 
Fig. 2. Cumulative release of fluorescein-labeled GDNF from 0.5 wt% fibrin fibers, nonheparinized (       ) 
vs. modified with 0.1% heparin (      ), over 7 days in PBS at 37°C. Fibers were loaded in overnight baths 
of (A) 500 ng/ml, (B) 1 g/ ml, (C) or 2 g/ ml fluorescein-labeled GDNF. Heparinized fibers show 



















































3.3 Effect of GDNF on NSC Proliferation 
NSC spheroids were seeded onto laminin-coated 24-well TCPS plates, then cultured under varying 
concentrations of GDNF in differentiation media. Metabolic activity of NSCs was measured using 
alamarBlue, and proliferation was reported relative to the initial metabolic activity of spheroids 4 hours 
after seeding. At 0, 2, and 5 ng/ml, relative proliferation was consistently lower than the corresponding 
readings of the 10 ng/ml group at the same time points. Lower proliferation at concentrations higher than 
10 ng/ml (25 ng/ml and 50 ng/ml) potentially indicates toxic GDNF dosages. Based on consistently higher 
relative values of NSC proliferation at each sampling time point, 10 ng/ml was determined to be the 
optimal concentration for NSC proliferation in differentiation media (Fig. 3). Readings of samples cultured 
with 10 ng/ml soluble GDNF displayed markedly higher proliferation compared to the control group, which 
was cultured in plain differentiation media, indicating that 10 ng/ml GDNF had a positive proliferative 
effect on NSCs. 10 ng/ml GDNF was accordingly chosen for subsequent 3D culture of NSC spheroids on 



























Fig. 3. NSC proliferation on TCPS cultured under varying concentrations of GDNF in differentiation 
media. 10 ng/ml GDNF was determined to be an optimal GDNF concentration for proliferation of NSCs. 
The greatest differences in proliferation compared to the control (differentiation media only) were observed 
in NSCs cultured with 10 ng/ml GDNF. Values corresponding to the same time points increased from 2 














































3.4 Inhibition of cell outgrowth from spheroids by heparin 
Scaffolds were cultured in maintenance media or differentiation media containing aprotinin, with 
GDNF immobilized or presented in soluble form in the media. GDNF was delivered either bound to 
scaffolds (physically entrapped in nonheparinized fibers) or soluble via culture media to determine any 
differences in presentation and thus release kinetics of GDNF to NSCs. Control scaffolds were cultured in 
the absence of GDNF.  Cell adhesion on scaffolds occurs quickly, and cells were observed growing out 
from their spheroid conformation and spreading in the orientation of the fibers as early as D1 after seeding 
onto unmodified fibers. The area covered by cells on unmodified fibers cultured in either maintenance or 
differentiation media with no GDNF present had more than doubled by D2. By D2 of culture in 
maintenance media without GDNF, the total area covered by spheroids on heparinized fibers had doubled 
as well. However, spheroids cultured in differentiation media without GDNF on heparinized fibers had 
expanded just over 50% after 2 days in culture (Fig. 4A, Table 3). Spreading of NSCs on fibers at early 
time points (4 hr, D1, D2) is of great interest, as rapid cell infiltration into a NGC may maximize the 
regenerative outcome. Cells that are seeded onto and proliferate on scaffolds prior to implantation can 
provide their own endogenous cues to enhance regeneration.  
Soluble GDNF added to media had a less pronounced effect on cell spreading at early time points 
overall. After 2 days in culture, cell coverage area on unmodified fibers cultured in maintenance media 
with 10 ng/ml GDNF had increased by 75.70% and by 67.71% on unmodified fibers cultured in 
differentiation media with 10 ng/ml GDNF. Cell spreading was again lower on heparinized fibers, with area 
of spheroid outgrowth increasing by 26.5% when cultured in maintenance media with 10 ng/ml GDNF. 
Total spheroid area on heparinized fibers cultured in differentiation media with 10 ng/ml GDNF steadily 
decreased over, falling to 68% of initial spheroid area by D2 of culture (Fig. 4B, Table 3). This was the 
only group in which a decrease in cell spreading was observed.  
A final group in which fibers had been loaded with GDNF overnight was studied. We aimed to load 10 
ng/ml GDNF into the fibers, as calculated based off of a calibration curve generated previously. 
Fluorescein labeled-GDNF was loaded into both heparinized and nonheparinized fibers at initial 
concentrations of 25, 50, 100, 500, and 1000 ng/ml overnight at 4°C. Total GDNF captured by fibers was 
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measured by fully degrading fibers and measuring the fluorescence of the degradation solution. 
Unmodified fibers were treated with 0.5 CU/ml plasmin only overnight at 37°C, while heparinized fibers 
were first soaked in 1 U/ml heparinase overnight at 37°C, followed by another overnight incubation in 0.5 
CU/ml plasmin. The cumulative releases at these concentrations was plotted to yield the calibration curve. 
A nearly three-fold increase in cell coverage was observed on unmodified fibers soaked overnight in 
GDNF and cultured in maintenance media for 2 days. Area covered by cells had nearly doubled on 
unmodified fibers soaked overnight in GDNF and cultured in differentiation media. A sizeable difference 
was observed between GDNF-bound heparinized fibers that were cultured for 2 days in either maintenance 
media or differentiation media. Spheroid coverage on heparinized fibers had increased by approximately 
131% in maintenance media compared to an increase of approximately 51% in differentiation media (Fig. 
4C, Table 3). 
Beyond D2 of culture, resolution of spheroid spreading became difficult to quantify, particularly on 
nonheparinized fibers, due to cells coalescing and proliferating along the length of the fibers. At D7, 
phalloidin staining was used to stain fixed cells for F-actin, a protein essential for important cellular 
functions such as cell division and migration. Spheroids cultured under all media conditions on 
nonheparinized fibers displayed significant spreading out of the initial cell aggregates (Fig. 5) compared to 
their heparinized counterparts that remained clustered together, with little outgrowth from their spheroid 
conformations (Fig. 5). However, slight outgrowth was observed from spheroids cultured on heparinized 
fibers in maintenance media only as well as in differentiation media with 10 ng/ml bound GDNF (Fig. 5). 
We hypothesize that heparinized fibers bind to the bFGF in maintenance media, thus reducing the 
maintenance media’s ability to facilitate NSC proliferation and outgrowth. The binding of heparin to bFGF 
in maintenance media effectively transforms maintenance media into differentiation media over time, thus 
reducing NSC proliferation. Consequently, we reasoned that culture conditions in differentiation media 
rather than maintenance media were most relevant for studying the effects of GDNF on NSC spreading. 
Outgrowth from spheroids was observed in all groups of nonheparinized fibers cultured in differentiation 
media. The area of spreading was greatest when spheroids had been cultured in differentiation media with 
soluble 10 ng/ml GDNF, slightly lower under culture in differentiation only, and lowest when cultured with 
10 ng/ml GDNF entrapped in the scaffolds prior to spheroid seeding. Despite measurements at D1 and D2 
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indicating an increase in cell coverage on the surfaces of heparinized scaffolds cultured in differentiation 
media and in differentiation media with 10 ng/ml bound-GDNF, slight outgrowth was only observed from 
the latter. This suggests that sustained delivery of GDNF over 7 days may have some proliferative effects 
on NSCs.  
Presentation of soluble GDNF was achieved by adding 10 ng/ml fresh to differentiation media with 
each media exchange every other day. Under these conditions, scaffold area covered by NSC spheroids 
seeded onto heparinized fibers decreased steadily within the first 2 days of culture, and D7 phalloidin 
staining showed that cells remained strictly spherical aggregates. A possible explanation for the negative 
effects on NSC spreading observed in this group may be that the soluble delivery of GDNF at 10 ng/ml 
may saturate GDNF receptors and ultimately be toxic to NSCs. This hypothesis and the observation of the 
beginnings of cell outgrowth from spheroids give cause for reversible binding of GDNF using heparin to 



















Type of Microfiber 
Scaffold 
Type of NSC 
Culture Media 
GDNF in System Change in Cell 
Spreading by D2 
Nonheparinized Maintenance 0 ng/ml 154.50% 
Nonheparinized Differentiation 0 ng/ml 141.48% 
0.1% Heparin Maintenance 0 ng/ml 108.76% 
0.1% Heparin Differentiation 0 ng/ml 68.73% 
    
Nonheparinized Maintenance 10 ng/ml (s) 75.70% 
Nonheparinized Differentiation 10 ng/ml (s) 67.71% 
0.1% Heparin Maintenance 10 ng/ml (s) 26.48% 
0.1% Heparin Differentiation 10 ng/ml (s) -32.05% 
    
Nonheparinized Maintenance 10 ng/ml (b) 188.40% 
Nonheparinized Differentiation 10 ng/ml (b) 89.98% 
0.1% Heparin Maintenance 10 ng/ml (b) 131.80% 
0.1% Heparin Differentiation 10 ng/ml (b) 51.15% 
 
Table 3. Percent change of total scaffold area covered by cells 2 days post-spheroid seeding on scaffolds, 
relative to area measured at 4 hr. Soluble delivery of GDNF is denoted (s), while presentation of “bound” 
GDNF is noted with (b).  In each delivery group, the greatest amount of early cell spreading was observed 
on nonheparinized fibers cultured in maintenance media, followed closely by nonheparinized fibers in 
differentiation media. On heparinized fibers, sustained delivery of GDNF appeared to have an effect on 
early cell spreading. Proliferation surpassed that of cells on heparinized fibers that were cultured in 
maintenance media only with no GDNF present. Spreading was lowest across all samples with soluble 





























NSC spreading on fibers loaded with 10 ng/ml GDNF prior to spheroid seeding 
 
Fig. 4. Early outgrowth from NSC spheroids seeded onto nonheparinized and heparinized electrospun 
hydrogel fibers, measured relative to initial area of spheroid seeding. Cells were cultured on fibers in the 
presence of no GDNF (A), 10 ng/ml soluble GDNF (B) , and 10 ng/ml bound GDNF (C). Relative changes 
in cell coverage area were lowest on all fibers when 10 ng/ml soluble GDNF was present. Sustained 
delivery of GDNF appeared to have a greater proliferative effect on NSCs than soluble delivery of GDNF 
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3.5 Effect of Heparin on NSC Phenotype and Morphology 
NSC spheroids were seeded onto fibrin hydrogel scaffolds that had either been surface modified with 
0.1 wt% heparin or remained untreated. Spheroids were then cultured in differentiation media with no 
additional growth factors. At D7 and D21, scaffolds were fixed and stained for III-tubulin/ nestin and 
GFAP/MAP2.  
Spheroids on nonheparinized fibers had spread out across the length of the fibers by D7, staining 
positive for both III-tubulin and nestin (Fig. 6A). However, cells that stained positive for III-tubulin 
only appeared sparingly on the periphery of fibers. By D21, NSCs stained positive for primarily for III-
tubulin, in high concentration along the edges of the fibers (Fig. 6B). MAP2/ GFAP staining did not reveal 
a dominant phenotype at D7 (Fig. 6C), but clear MAP2-positive cells were observed at D21, indicating 
differentiation of NSCs into neurons (Fig. 6D). At D21 in culture, cells cultured on nonheparinized fibers 
that had degraded appreciably appeared to have remodeled the fibers; neurons appeared in tight, thin bands 
that were arranged in the orientation of the fibers and spanned the width of each individual remaining fiber 
respectively. From these results, we conclude that NSCs retain enough stem cell characteristics on 
nonheparinized fibers at D7 that they generally stain indiscriminately for III-tubulin and nestin. 
On heparinized fibers, NSCs began spreading out from spheroids following fiber alignment but 
remained in distinct cell clusters. Staining of D21 samples indicated that some spheroids remained in tact 
while others had broken apart into individual cells. However, cells from fragmented spheroids had not 
migrated towards one other to form large patches of cells. A greater portion of cells on heparinized fibers 
stained positive for III-tubulin at D7 (Fig. 6E), although there did not appear to be a dominant cell 
marker at D21 (Fig. 6F). MAP2/GFAP staining at D7 indicated the presence of mostly neurons with the 
appearance of astrocytes on the fringes of spheroids that had begun breaking apart (Fig. 6G). Likewise, at 
D21, cells stained positive for MAP2 and GFAP. GFAP-positive cells were detected solely on the edges of 
spheroids. 
Differentiation media is growth factor-free, no additional growth factors were added to the systems, the 
fibers were spun under the same conditions, and cells were seeded in an identical manner. Thus, we 























Fig. 6. Immunostained NSCs cultured in differentiation media. Spheroids on nonheparinized fibers were 
fixed and stained for III-tubulin (red) and nestin (green) at D7 (A) and D21 (B), MAP2 (green) and 
GFAP (red) staining at D7 (C) and D21 (D). MAP2 stains for dendrites, indicating formation of neurons. 
III-tubulin/ nestin staining of spheroids on heparinized fibers fixed at D7 (E) and D21 (F). MAP2/GFAP 
staining on heparinized fibers fixed at D7 (G) and D21 (F). All samples were DAPI stained (blue). 
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3.6 Effects of GDNF on NSC Phenotype and Morphology in 3D Model 
NSC spheroids were seeded onto TCPS and cultured in maintenance and differentiation media 
under various GDNF conditions, namely 2 ng/ml vs. 10 ng/ml, soluble delivery of factor vs. release of 
bound factor. Using alamarBlue to quantitatively measure metabolic activity and thus proliferation, we 
found 10 ng/ml to be an optimal concentration of GDNF in both maintenance and differentiation media for 
promoting proliferation of NSC spheroids in 2D culture. We then compared the effects of soluble vs. bound 
delivery of 10 ng/ml of GDNF on NSC spheroids cultured in 3D on fibrin hydrogel microfibers. 2 ng/ml 
GDNF, the lowest concentration of GDNF that was screened on TCPS, was also studied in the 3D model to 
determine whether a low level of GDNF would support NSC proliferation and viability. Spheroids cultured 
on scaffolds were fixed and stained with DAPI, III-tubulin/ nestin, and MAP2/GFAP as before.  
Nonheparinized fibers stained at D7 did not stain distinguishably for either III-tubulin or nestin at 
D7 (Fig. 7A). However, at D21, fewer cells appeared to stain positive for III-tubulin compared to cells at 
D7 (Fig. 7B). Additionally, more astrocytes than neurons were observed at D7 (Fig. 7C). At D21, it was 
unclear which phenotype was more prevalent throughout the fibers, as DAPI revealed high confluence of 
cells spreading out along the entire length and width of nonheparinized fibers, but the ends of the fibers 
stained positive nearly exclusively for MAP2 (Fig. 7D).  
Spheroids on heparinized fibers began spreading at D7, and cells stained mostly positive for nestin 
(Fig. 7E). At D21, cells stained positive for III-tubulin only on the edges of fibers (Fig. 7F). A 
predominant NSC phenotype was not detected inside the fibers at either D7 (Fig. 7G) or D21 (Fig. 7H), but 
the edges of the fibers at both D7 and D21 stained positive for MAP2. DAPI staining also revealed greater 
outgrowth from spheroids at the later time point.   
On nonheparinized fibers cultured in maintenance media and loaded with 2 ng/ml GDNF prior to 
spheroid seeding, cells had migrated out of spheroids and began proliferating in the orientation of the fibers 
by D7. Cells at this time point also stained positive for III-tubulin on the periphery of nonheparinized 
fibers (Fig. 8A). Distinct areas of spreading and outgrowth from spheroids along the length of the fibers 
were observed, and MAP2/GFAP staining indicated the presence of astrocytes at D7 as well as some 
neurons towards the ends of the fibers (Fig. 8C). At D21, cells at the edges of the fibers stained positive for 
nestin and DAPI staining revealed cells having spread out to fill the entire surfaces of fibers (Fig. 8B). No 
33 
cells were stained due to poor spheroid seeding on nonheparinized D21 samples loaded with 2 ng/ml 
GDNF overnight.  
Heparinized fibers loaded with 10 ng/ml bound GDNF stained positive for both for III-tubulin 
and nestin at D7 (Fig. 9A) and D21 (Fig. 9B), with no particular preference for either stain. Cells at D7 had 
migrated out of spheroids, but remained largely separate from one another, whereas by D21, cells had 
aggregated and were expanding along the fibers. NSCs also almost exclusively stained positive for GFAP 
at D7 (Fig. 9C), indicating formation of astrocytes. MAP2/GFAP staining at D21 revealed several 
instances of dendrite growth in the same orientation as the microfibers, although the main cell constituents 
remained astrocytes (Fig. 9D).  
NSCs appeared to have migrated out of spheroids along the orientation of fibers at D7 on 
nonheparinized fibers cultured in maintenance media with 10 ng/ml soluble GDNF. Fixed cells stained 
positive for III-tubulin at the ends of and nestin towards the centers of the fibers (Fig. 10A), as well as 
for GFAP (Fig. 10C) at D7. DAPI staining revealed cells had proliferated across the entirety of fiber 
surfaces at D21. Cells stained positive for both III-tubulin and nestin on fibers at D21 (Fig. 10B). MAP2 
positive cells were detected across all remaining sections of fiber that had not degraded by D21, indicating 
the presence of neurons that had grown outwards in bands in the direction of the fibers (Fig. 10D).  
Cells that were initially seeded as spheroids on heparinized fibers and exposed to 10 ng/ml soluble 
GDNF in maintenance media had largely migrated out by D7, although distinct patches of cells were still 
recorded. Cells stained positive for nestin, and minimal III-tubulin was detected at D7. Staining with 
DAPI also revealed cells growing in the direction of the fibers (Fig. 10E). No cells stained positive for 
MAP2 at D7 (Fig. 10G). At D21, staining still exposed several areas where spheroids had expanded in the 
direction of the fibers yet remained separate from other spheroids. More cells staining positive for III-
tubulin were detected, and with almost all III-tubulin stained cells appearing on the edges of the fibers. 
D21 DAPI staining also revealed a clear preferential direction of cell growth along the length of the fibers 
(Fig. 10F). Large areas of GFAP positive cells were observed at D21, and MAP2 was also detected in faint 
bands in the direction of the fibers (Fig. 10H).  
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Immunostaining of samples fixed at D21 revealed that the presence of heparin inhibited cells from 
spreading out from the initial aggregates under culture in maintenance media only as well as in 
differentiation media only. However, in general, when GDNF was present in culture, spheroids appeared to 
be able to spread out on the heparinized fibers to a greater extent. Samples cultured with 10 ng/ml bound 
GDNF in maintenance media did not stain positive for cells, indicating poor spheroid seeding in this group. 
10 ng/ml GDNF was previously shown in 2D culture to be an optimal concentration for promoting NSC 
proliferation.  
Cells on unmodified fibers after D7 of culture with 2 ng/ml soluble GDNF stained positive for both 
III-tubulin/ nestin, with a greater concentration of III-tubulin positive cells. Cells of the 2 ng/ml 
“bound” GDNF delivery group on nonheparinized fibers at D7 stained positive largely for III-tubulin. 
However, D21 III-tubulin/ nestin staining of samples from both groups of 2 ng/ml GDNF delivery 
indicated a greater concentration of cells that stained positive for nestin, an early neural stem cell marker, 
rather than  III-tubulin, a neuronal marker. Cell spreading was unaffected in either group. This 
unexpected result may indicate that 2 ng/ml GDNF is an insufficient dosage of GDNF to significantly 
influence neuronal differentiation on nonheparinized fibers. On the other hand, at D21, cells stained 
positive exclusively for MAP2 on nonheparinized fibers cultured with 10 ng/ml soluble GDNF, with no 
indication of the presence of astrocytes, suggesting target delivery of 10 ng/ml GDNF to NSCs cultured in 
a 3D model may enhance and direct neuronal outgrowth. 
On heparinized fibers, all groups stained positive for nestin at D7, and concentrated areas of cells 
cultured with 10 ng/ml soluble GDNF and in differentiation media only also stained positive for III-
tubulin. At D21, all samples stained either a comparable or noticeably lower degree for nestin. Samples of 
the groups cultured in maintenance media only and with 2 ng/ml soluble GDNF stained positive almost 
entirely for III-tubulin. A lack of pronounced difference in differentiation between samples treated with 2 
ng/ ml GDNF and with 10 ng/ml GDNF may be due to the presence of heparin sequestering growth factors 
released by the cells endogenously as well as GDNF, bFGF, and EGF delivered in culture, consequently 
playing an undetermined role in the promotion or inhibition of NSC differentiation. 
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The greatest concentration of cells that stained positive for GFAP, an astrocytic marker, appeared 
on the edges of fibers on which NSCs had migrated out of spheroids as well as outlining spheroids that 
remained in tact regardless of degree of heparinization of the scaffold surfaces. On unmodified fibers, cells 
stained positive for GFAP at varying degrees under all culture conditions, although cells cultured in 
maintenance media only and in differentiation media only stained predominantly for MAP2 at D7. By D21, 
GFAP staining was minimal in nearly all unmodified fibers, with the exception of the 2 ng/ml soluble 
GDNF delivery group, in which cells on the edges of the fiber stained positive for GFAP. However, cells 
cultured on heparinized fibers under all culture conditions, regardless of delivery method and concentration 
of GDNF, stained positive for both astrocytes and neurons even at D21. The observation of concentrated 
areas of cells that stained positive for GFAP at D21 on heparinized fibers but not on nonheparinized fibers 
may suggest that the presence of heparin, via recruitment and release of neurotrophic factors, plays a role in 
influencing cell lineage as NSCs differentiate. As astrocytes are closely associated with neuronal synapses 
and provide metabolic support to neurons, the ability to sustain both phenotypes in culture can potentially 
be exploited for applications in treatment of neurodegenerative diseases and disorders. 
A direct comparison of NSCs cultured on unmodified fibers cultured in differentiation media with 
soluble growth factor and NSCs seeded onto heparinized fibers with bound growth factors in differentiation 
media would provide insight into how soluble and sustained delivery of biochemical cues independently 
affect differentiation and cell phenotype. Maintenance media was used in this study to promote cell 
proliferation, but bFGF and EGF in the media may bind to heparin or play an undetermined synergistic or 
competitive role when GDNF is present in the system. Growth factors secreted by NSCs may also bind to 
and be subsequently released by heparin at a later time point. Culturing NSCs on fibers in differentiation 
media, where the only exogenous growth factor present is GDNF, would provide a means of studying the 
effect of GDNF on NSC proliferation and phenotype via culture on unmodified fibers. Through close study 
of the saturation levels of growth factors bound to heparin, we can tune the degree of heparinization so as 
to minimize free heparin groups to which endogenous growth factors released post-cell seeding can bind to 
and potentially mute any effects of GDNF on cellular response. Additionally, lack of cells on several 
heparinized fiber groups indicates a need for improving cell adhesion when scaffold surfaces have been 
modified. A sandwich configuration that consists of a middle heparinized layer with bound growth factors 
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wrapped in unmodified fibers onto which spheroids would be seeded is proposed and will be evaluated in 













































Fig. 7. Immunostained NSCs on nonheparinized  (A-D) and heparinized (E-H) fibers loaded with 2 ng/ml 
soluble GDNF in maintenance media. Spheroids on nonheparinized fibers were fixed and stained for III-
tubulin/ nestin at D7 (A) and D21 (B). MAP2/GFAP staining revealed differences in NSC phenotype at D7 
(C) and D21 (D). Heparinized fibers were stained for III-tubulin/ nestin at D7 (E) and D21 (F), as well 
as MAP2/GFAP at D7 (G) and D21 (H). On nonheparinized fibers, cells stained positive for both III-
tubulin and nestin at D7 and D21. More cells stained positive for GFAP at D7 and for MAP2 at D21. Cells 
on the edges of heparinized fibers stained positive for III-tubulin at D21. Both GFAP and MAP2 positive 
cells were observed at D21 on heparinized fibers. All fibers were stained with DAPI. 








































Fig. 8. Immunostained NSCs on nonheparinized fibers loaded with 2 ng/ml bound GDNF and cultured in 
maintenance media. All samples were stained with DAPI. Spheroids on nonheparinized fibers were fixed 
and stained for III-tubulin/ nestin at D7 (A) and D21 (B). Fixed spheroids were also stained for 
MAP2/GFAP at D7 (C). Cells stained positive for III-tubulin and MAP2 at D7. At D21, cells stained 
positive for predominately nestin. MAP2/GFAP staining at D21 revealed no cells, which can be attributed 












































Fig. 9. Immunostained NSCs on heparinized fibers loaded with 2 ng/ml bound GDNF were stained for 
III-tubulin/ nestin at D7 (A) and D21 (B), as well as MAP2/GFAP at D7 (C) and D21 (D). All samples 
were stained with DAPI. Cells had migrated out of spheroids but remained separate from one another by 
D7. At D7, cells stained positive for both III-tubulin and nestin at D7 and almost exclusively for GFAP, 
indicating presence of astrocytes. NSCs had aggregated and grown following the direction of fibers by 
D21. Cells fixed at this time point stained positive for both III-tubulin and nestin, as well as for both 
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Fig. 10. Fixed and immunostained NSCs on nonheparinized (A-D) and heparinized (E-H) fibers cultured in 
maintenance media with 10 ng/ml soluble GDNF. All samples were stained with DAPI. Cells on 
nonheparinized fibers were stained for III-tubulin/ nestin at D7 (A) and D21 (B), as well as MAP2/GFAP 
at D7 (C) and D21 (D). Cells on heparinized fibers were stained for III-tubulin/ nestin at D7 (E) and D21 
(F), as well as MAP2/GFAP at D7 (G) and D21 (H). On nonheparinized fibers, cells stained positive for 
GFAP only at D7 and MAP2 only at D21. On heparinized fibers, cells had largely migrated out of 
spheroids by D7, although distinct patches of cells were still observed at D21. Cells stained positive 
primarily for nestin at D7 and both nestin and III-tubulin (on the edges of fibers) at D21. Both GFAP and 
MAP2 positive cells were observed at D21. 


































We report a simple, scalable platform for capturing growth factors on the surface of aligned, hydrogel 
fibers using heparin.  Fibrin scaffolds were selected for this study, but the EDC/NHS coupling of heparin 
employed affords great flexibility to the system in that any biopolymer hydrogel containing primary 
amines, or carboxylic acid groups when a diamine linker is used, can be functionalized. The utility of this 
surface conjugation method is further extended by the large number of growth factors that contain heparin-
binding domains and can thus be studied in the context of specific regenerative medicine applications.  
We demonstrated sustained release of FITC-lysozyme as well as GDNF from heparin-conjugated 
fibrin hydrogel microfibers. Percent of heparinization is defined as weight of heparin dissolved per volume 
of final soak solution (w/v), which consisted of a 1:1 ratio of 0.05 MES buffer to PBS. Thus, the 
concentration of the heparin soak bath can be easily tuned. While changes in percent heparinization would 
also require tuning of factor uptake and release, this could be useful if a greater number of free heparin 
groups on fiber scaffolds or different release kinetics for the delivery of growth factor(s) beyond GDNF 
were sought.  
NSCs on nonheparinized fibers migrated out of spheroids quickly after seeding and continued to grow 
in the direction of the fibers. Heparin appeared to inhibit spreading of neural stem cells out of spheroids on 
hydrogel scaffolds in the absence of any growth factors. This suggests heparin binds to either NSC surfaces 
or endogenous growth factors released by NSCs, thus restricting the transmission of biochemical cues to 
signal outgrowth from spheroids across fiber surfaces. However, the presence of GDNF in culture on 
heparinized fibers appeared to supersede the inhibitory effects of heparin alone on cell spreading.  
Notably, NSC phenotype differed significantly on heparinized and nonheparinized fibers for all 
conditions of GDNF, regardless of concentration or delivery method. Cells on nonheparinized fibers 
stained positive exclusively for neurons, whereas all heparinized samples stained positive for both 
astrocytes and neurons. Although the precise role of astrocytes in the neurodegenerative diseases remains 
unclear, there are many indications of mechanisms by which astrocytes support neurons in the normal 
brain. In the literature, neurons co-cultured with astrocytes have exhibited higher levels of glutathione, an 
antioxidant that prevents damage to cellular components, compared to neurons cultured alone.[31, 32] 
Likewise, astrocytes take up glutamate and convert it into glutamine, which is released to the extracellular 
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space where it is taken up by neurons. Neurons then use glutamine to synthesize glutamate in order to 
replenish the neurotransmitter pool. Astrocytes also regulate neuronal activation by extracellular potassium 
uptake and help maintain ion gradients. As astrocytes upregulate glucose transporters to provide energy to 
dying neuronal cells, they are believed to play a crucial role in the improvement of energy metabolism in 
chronic neurodegenerative diseases.[33]  
Astrocyte functions vary with respect to specific neurodegenerative diseases. For example, in 
Alzheimer’s disease (AD), astrocytes accumulate neuron-derived amyloid material that results from local 
neurodegeneration. GFAP+ amyloid plaques then form when astrocytes undergo cell death as a result of 
substantial neurodegenerative debris accumulation. The disease process also increases calcium signaling 
between astrocytes, which is believed to contribute to the dysfunction or death of neurons.[34-37] 
Preservation of astrocyte function is thus a keystone goal against AD. In Parkinson’s disease (PD), the 
second most prevalent neurodegenerative disease after AD, emphasis is shifting from studying the loss of 
dopaminergic neurons and depletion of dopamine to understanding the role nonneuronal cells play in 
producing neuroprotective functions in PD. Exposure of astrocytes to nitric oxide increases glutathione 
production by astrocytes. Increased availability of glutathione to neurons in turn makes neurons less 
susceptible to reactive nitrogen species. In PD patients, glutathione-containing cells have been found in 
regions with preserved dopaminergic neurons, further supporting the theory that astrocytes serve a 
neuroprotective purpose in PD.[38]   
Contrarily, astrocyte involvement in neurodegenerative contexts has also been observed. In 
amyotrophic lateral syndrome (ALS) patients, increased astrocyte activation and expression of 
inflammatory markers are established hallmarks of ALS disease progression.[39, 40] Likewise, exposure of 
astrocytes in multiple sclerosis (MS) plaques to inflammatory cytokines has been shown to trigger 
unregulated inflammatory responses. Increased noradrenalin levels leads to axonal and myelin damage in 
MS patients.[41, 42]  
Overall, the neurodegenerative and neuroprotective mechanisms astrocytes are involved in indicate 
that modulating astrocyte function may be an important consideration in developing successful therapeutic 
strategies in the treatment of neurodegenerative disorders.[43] The results from our study indicate a 
phenotypic distinction in differentiated NSCs cultured on heparinized vs. nonheparinized fibers, suggesting 
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that in addition to providing topographic and biochemical cues to enhance cell survival, our surface-
modified fibers can potentially influence stem cell differentiation. Individual aspects of the platform 
proposed, such as materials selection, degree of heparinization, release kinetics, and growth factors to be 
delivered, can all be tuned in order to gain a deeper understanding of specific pathological states and 
subsequently design therapeutic treatments to combat these diseases.    
 
 
5. Conclusion  
The utility of hydrogel microfibers is significantly improved by conjugating heparin to the surfaces of 
these fibers, thereby providing a means for binding and controlling the release kinetics of growth factors in 
vitro. The method of heparinization used can easily be scaled up or down, and selection of biochemical 
cues is only limited by the lack of heparin-binding site on the growth factors themselves. Due to the post-
electrospinning modification of the fibers using heparin, structural integrity and cross-linking of the 
hydrogel fibers is not compromised by the addition of heparin, and a wide range of biopolymers can be 
used in scaffold formation.  
Fibrin fibers modified with heparin to bind GDNF displayed lower release rates relative to those of 
unmodified fibers loaded at the same concentration, indicating capture and sustained release of GDNF. Due 
to its high negative charge, heparin appears to protect fibers from degradation by plasmin delivered 
exogenously in acellular studies and proteases secreted by NSCs. Immunostaining revealed that heparin 
alone inhibited spreading of NSCs out of spheroids seeded onto scaffolds, but the presence of GDNF 
seemed to override these inhibitory effects to enhance cell outgrowth. Finally, a phenotypic difference was 
observed in preliminary cell studies: unmodified fibers stained positive nearly exclusively for neurons, 
while heparinized samples stained positive for both astrocytes and neurons. 
Prolonged release of GDNF, protection of underlying fibrin scaffolds, and influence over NSC 
phenotype were achieved using heparin conjugated to the surface of fibrin hydrogel microfibers. NSCs, 
GDNF, and fibrin were selected for the preliminary cell culture study, but there are few restrictions on cell 
line, growth factor(s), and scaffold biopolymer. Thus, the versatility and ease of adaptability of this 
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Appendix 1. Schematic of electrospinning set-up designed by Zhang et al. A polymer solution is extruded 
at a fixed rate from a syringe fitted with a blunted 27 G needle tip (A). A voltage between 3-5 kV is applied 
to the polymer solution, resulting in the formation of a Taylor cone as the applied electric field overcomes 
the solution viscosity (B-1). When the electrical field threshold has been surpassed, a finely charged 
polymer jet emerges from the tip of the Taylor cone and is stretched under the electrical force applied (B-
2). The jet sprays as a continuous fiber onto a grounded, rotating collector filled with a cross-linking bath. 
The rotating wheel mechanically stretches the polymer jet (B-3). Fiber alignment is further induced as the 
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